Understanding Hodgkin Lymphoma
- Pittsburgh Penguins legend Mario Lemieux, now 61, recently received a standing ovation as he helped open the franchise’s 60th anniversary season.
- In March 1993, Lemieux finished his final radiation treatment for Hodgkin lymphoma in Pittsburgh, then flew to Philadelphia and scored a goal that same night.
- Hodgkin lymphoma is a cancer of the lymphatic system. Treatment has changed dramatically since 1993. Radiation is more targeted, PET scans help doctors tailor therapy, and in March 2026 the FDA approved the immunotherapy nivolumab with chemotherapy for newly diagnosed advanced classic Hodgkin lymphoma.
The Hockey Hall of Famer dropped the ceremonial first puck at the Penguins’ October 3 home opener against the Montreal Canadiens, the same team Pittsburgh faced in its first home game in 1967, according to NHL.com.
Read More
A Diagnosis at the Peak of His Career
Lemieux was just 27 and leading the NHL in scoring, with 104 points [goals scored plus goals he helped set up] in 40 games, when he learned he had cancer.On January 12, 1993, Lemieux announced he had been diagnosed with Hodgkin lymphoma, which came after doctors removed a swollen lymph node from his neck and examined it under a microscope, a test known as a biopsy.
He stepped away from the team to begin radiation therapy, a treatment that uses high-energy beams, similar to X-rays, to destroy cancer cells in a specific area of the body. His doctors were hopeful because the cancer had been caught at an early stage, meaning it had not spread widely. Still, few people expected him back on the ice so soon.
On March 2, 1993, Lemieux finished his last radiation treatment in Pittsburgh. Instead of going home to rest, he flew across Pennsylvania to play that night against the Philadelphia Flyers, the Penguins’ biggest rival, according to NHL.com.
The effects of treatment were easy to see. According to his former teammate Kjell Samuelsson, Lemieux had lost hair on the back of his head and wore a black turtleneck under his jersey to cover marks the radiation left on his skin. Both are common side effects. Radiation can cause hair loss in the area being treated, and it can make the skin red and sore, much like a sunburn.
Before the game, Flyers fans, who usually boo visiting stars, stood and gave Lemieux a long ovation. Early in the second period, he scored a goal. Less than two minutes later, he set up teammate Kevin Stevens for another goal during a power play. (A power play happens when one team has an extra player on the ice because a player on the other team is serving a penalty.)
The Penguins lost 5-4, but Lemieux had two points in his first game after missing 23. “It was like he never left,” Samuelsson said, according to NHL.com.
What came next was remarkable. In the Penguins’ last 20 games of the season, Lemieux earned 56 points, according to NHL.com. He passed Buffalo’s Pat LaFontaine and won the scoring title, the award given to the player with the most points in a season, finishing with 160.
That same year, Lemieux started the Mario Lemieux Foundation, which supports cancer patients, their families, and cancer research, according to the foundation.
Fatigue from radiation, a deep tiredness that rest doesn’t always fix, along with back problems, kept Lemieux out for the 1994-95 season, but he returned the next year and won the scoring title again, according to the Pittsburgh Tribune-Review.

Understanding Hodgkin Lymphoma
Hodgkin lymphoma is relatively rare. The American Cancer Society estimates about 8,920 new cases and about 1,100 deaths in the U.S. in 2026. It’s most common in early adulthood, especially in people in their 20s, and the risk rises again after age 55. The average age at diagnosis is 39. It’s also the most common cancer diagnosed in teens ages 15 to 19.
Lymphomas are a type of blood cancer that begin in lymphocytes, a type of white blood cell that helps the body fight infection. Lymphomas fall into two main groups: Hodgkin lymphoma and non-Hodgkin lymphoma. Non-Hodgkin lymphoma is far more common.
“Lymphoma is split up into a number of different categories,” Dr. Elise Chong, a medical oncologist at Penn Medicine, previously told SurvivorNet.
“The first distinguishing breakpoint, if you will, is non-Hodgkin lymphoma versus Hodgkin lymphoma,” she added, “and those sound like two different categories. But non-Hodgkin lymphoma comprises the majority of lymphoma, and Hodgkin lymphoma is a single specific type of lymphoma.”
What Kind of Lymphoma Do You Have? Why Your Type Matters
Hodgkin lymphoma usually starts in B cells, a type of lymphocyte that makes proteins called antibodies to help protect the body from germs. When these cells become cancerous, they don’t work the way they should, which can make it harder for the body to fight infections.
Under a microscope, Hodgkin lymphoma shows large, abnormal cells called Reed-Sternberg cells. Finding these cells helps doctors tell it apart from non-Hodgkin lymphoma. The two types also tend to spread differently. Hodgkin lymphoma usually moves in an orderly way from one group of lymph nodes to the next, while non-Hodgkin lymphoma is more likely to appear in scattered groups of nodes throughout the body. Because they behave and respond to treatment differently, it’s important to know which type you have.
Common symptoms of Hodgkin lymphoma include a painless lump or swelling in the neck, armpit, or groin caused by enlarged lymph nodes, itchy skin that can sometimes be severe, fevers, drenching night sweats, unexplained weight loss, and ongoing tiredness, or fatigue. Some people also notice pain in their lymph nodes after drinking alcohol, an uncommon but notable sign.
These symptoms often have other, less serious causes. But a swollen lymph node that doesn’t go away after a few weeks is worth getting checked by a doctor.
How Hodgkin Lymphoma Is Treated, Then and Now
Hodgkin lymphoma was already one of the most curable cancers when Lemieux was treated in 1993. Today, doctors aim not only to cure the disease but also to spare patients from harmful side effects years later.
Treatment depends on the type and stage of the cancer, meaning how far it has spread, along with other factors such as how large the tumors are, according to the American Cancer Society. Chemotherapy, which uses drugs to kill cancer cells, is part of treatment for most patients. In the early stages, radiation may be added because stage I and II lymphomas tend to respond well to it.
Treatment is more personalized. Doctors often order a PET scan, an imaging test that shows how active cancer cells are, after a few rounds of chemotherapy to see how well treatment is working and decide how much more is needed, according to the American Cancer Society. In a study led by Dr. Ann LaCasce of Dana-Farber Cancer Institute and published in the Journal of Clinical Oncology, 78% of patients with large, early-stage tumors were able to skip radiation after a PET scan showed their cancer was responding well, and they still had excellent results.
Radiation has long-term risks. Radiation can cause problems that show up years later, including a higher risk of second cancers and heart disease, the researchers behind that study noted.
Immunotherapy is now a frontline option. Immunotherapy is a treatment that helps the immune system find and attack cancer cells. In March 2026, the FDA approved the immunotherapy drug nivolumab (Opdivo), given with a chemotherapy combination called AVD, for patients 12 and older with newly diagnosed stage III or IV classic Hodgkin lymphoma. In the large SWOG S1826 trial behind the approval, patients lived longer without their cancer returning on the nivolumab combination than on the previous standard, which paired AVD with the targeted drug brentuximab vedotin (Adcetris). They also had less nerve damage, and fewer stopped treatment early.
It was also the first time the FDA approved a new Hodgkin lymphoma drug for children and adults at the same time, according to the University at Buffalo.
More options if the cancer comes back. If the cancer returns, known as a relapse, options can include different chemotherapy drugs, radiation, and a stem cell transplant, which replaces damaged bone marrow with healthy blood-forming cells, according to the American Cancer Society. Immunotherapy and targeted drugs offer additional paths, and more treatments are being tested in clinical trials.
Thanks to these advances, many patients make a full recovery. Dr. Chong told SurvivorNet that she always reassures patients diagnosed with advanced-stage lymphoma that, unlike with some other cancers, an advanced diagnosis does not mean the disease can’t be treated successfully.
Avoiding Provider Bias – Is Your Doctor Understanding You?
While your doctor has undergone years of training and practice, they are still human, and may come with their own set of biases that can impact how they treat patients.
To combat these biases and really get the most out of your interactions with your doctor, you should provide her or him with plenty of information about your life and ask plenty of questions when things aren’t clear. To better understand how you should approach conversations with your doctor, we previously spoke with Dr. Dana Chase, gynecologic oncologist at Arizona Oncology.
According to Dr. Chase, physicians, like many of us, can be a bit biased when seeing patients. She made it clear that these biases are rarely sinister, but rather unconscious and more subtle.
She explained, “We have certain beliefs that we don’t know about. We might look, for example, at an older woman, and just by the way she looks we might make certain assumptions, and we might not even know that we’re making these assumptions.”
Let’s Talk About Provider Bias
Clearing up misconceptions is important, but so is understanding what your doctor is telling you, Dr. Chase noted. Overall, she advises women to speak up and ask questions when they don’t understand something.
“It’s never a bad thing to ask for something to be repeated, or to ask the doctors to explain it in different terms.”
So next time you go to your physician, speak up if you need clarity, so your doctor can understand you and you can understand them.
Questions for Your Doctor
If you are dealing with a lymphoma diagnosis, it’s important to ask your doctor a series of questions so you will have an idea of what your next steps will look like. To help you during this difficult time, SurvivorNet has some questions to kickstart your conversation with your physician.
Also, make use of SurvivorNet’s proprietary AI tool “My Health Questions” to further aid your cancer journey.
- What type of lymphoma do I have?
- What does my pathology report say about my diagnosis?
- Should I get a second opinion before I explore possible treatment options?
- Based on my diagnosis, what do you anticipate my treatment path?
- What common side effects should I expect when I begin treatment?
- Will I be able to continue working and performing normal daily activities during treatment?
- Where can I get help working with the insurance company regarding treatment costs?
How Do You Know if Your Lymphoma Has Changed Into an Aggressive Form?
Contributing: SurvivorNet Staff
Learn more about SurvivorNet's rigorous medical review process.
